S. 4494: A bill to prioritize funding for an expanded and sustained national investment in biomedical research.
Sponsors
4 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| May. 12, 2026 | Introduced in Senate |
| May. 12, 2026 | Read twice and referred to the Committee on Appropriations. (text: CR S2239) |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.